Prognostic value of whole-body diffusion-weighted imaging with background body signal suppression in CRPC patients undergoing Ra-223 therapy: an exploratory analysis
DWIBS is a valuable tool for monitoring treatment response and predicting outcome in patients with CRPC undergoing Ra-223 therapy. Early intervention or treatment modification is recommended for patients with DWIBS-PD.
Authors
- Nae Takizawa (ORCID: https://orcid.org/0000-0001-6469-7546)
- Yumiko Kono (ORCID: https://orcid.org/0000-0002-7977-0272)
- Kenta Takayasu (ORCID: https://orcid.org/0000-0003-3907-1757)
- Noboru Tanigawa (ORCID: https://orcid.org/0000-0002-7283-3381)
- Junichi Ikeda (ORCID: https://orcid.org/0000-0002-0797-8525)
- Hisanori Taniguchi (ORCID: https://orcid.org/0000-0002-7404-0369)
- Masaaki Yanishi (ORCID: https://orcid.org/0000-0002-2050-886X)
- Keita Utsunomiya (ORCID: https://orcid.org/0000-0002-0532-9775)
- Satoaki Nakamura (ORCID: https://orcid.org/0000-0001-5721-3734)
- Hidefumi Kinoshita (ORCID: https://orcid.org/0000-0002-6481-1967)
- Yasuhiro Ueno
- Kaoru Maruyama
Institutions
- Kansai Medical University (JP)
Publication Details
- Journal
- Japanese Journal of Radiology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1007/s11604-025-01817-2
- Citations
- 2
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- Kansai Medical University